Ridgeview Instruments - LigandTracer

About Ridgeview Instruments - LigandTracer

A Dose Handling & Robotics player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• PR Newswire · 2026-10-07
  Ridgeview Instruments Ligandtracer announces Phase II readout for lead theranostic candidate
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Nuclear Medicine Today · 2026-05-24
  Ridgeview Instruments Ligandtracer expands cyclotron capacity to meet Lu-177 demand
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• STAT News · 2026-12-05
  Ridgeview Instruments Ligandtracer signs supply agreement to support late-stage trials
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Imaging Wire · 2026-11-10
  Ridgeview Instruments Ligandtracer appoints new Chief Medical Officer ahead of pivotal trial
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• BioPharma Reporter · 2026-10-15
  Ridgeview Instruments Ligandtracer publishes dosimetry data at SNMMI 2026
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.